Latest Advances

  • Condition: Encephalopathy with loiasis
  • Journal: Parasitology international
  • Treatment Used: Albendazole
  • Number of Patients: 1
  • Published —
The study researched the relationship between Albendazole and encephalopathy with loiasis.
  • Condition: Falciparum Malaria, Loiasis and Babesiosis
  • Journal: The Journal of infection
  • Treatment Used: Apheresis
  • Number of Patients: 126
  • Published —
In this analysis, researchers evaluated the effectiveness of apheresis for the treatment of falciparum malaria, loiasis and babesiosis.
  • Condition: Onchocerciasis in the Democratic Republic of Congo
  • Journal: BMC pharmacology & toxicology
  • Treatment Used: Ivermectin (CDTI)
  • Number of Patients: 15552588
  • Published —
This study determined the frequency of post-ivermectin (CDTI) severe adverse effects (SAE) as well as factors associated with the occurrence of severe adverse effects in the treatment of onchocerciasis (river blindness).
  • Condition: Adults with Wuchereria bancrofti infection in Côte d'Ivoire
  • Journal: PLoS neglected tropical diseases
  • Treatment Used: Diethylcarbamazine, albendazole and ivermectin
  • Number of Patients: 56
  • Published —
The study researched the effects of diethylcarbamazine, albendazole and ivermectin for adults with Wuchereria bancrofti infection in Côte d'Ivoire.
  • Condition: Lymphatic filariasis
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: Albendazole alone or in combination with microfilaricidal drugs
  • Number of Patients: 8713
  • Published —
This study assesses the effects of Albendazole alone, and the effects of adding Albendazole to Diethylcarbamazine (DEC) or Ivermectin, in people and communities with lymphatic filariasis.
Showing 1-5 of 5